Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COPD
COVID-19
Dermatology
Diabetes
Epilepsy
Gastroenterology
Hematology
Hepatitis
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Rheumatoid Arthritis
RSV
Schizophrenia
Shingles
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
Generic Drug Review June 2019
Biosimilars: Not Simply Generics
With the entry of biosimilars into the U.S. market, it is important for pharmacists to understand these products and how they differ from generic medications.
FDA Update on Recent Voluntary ARB Drug Recalls
Recent voluntary recalls of certain angiotensin II receptor blockers have heightened scrutiny of the non-U.S. manufacturing of drugs marketed in the U.S. and of FDA oversight of the process.
September 2024
In This Issue
Digital Magazine
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
Gastroenterology
• October 2026
• 2.00 Credits
Evolving Therapies for Metabolic Liver Disease
Urology, Women's Health
• September 2026
• 2.00 Credits
Managing Overactive Bladder in Syndrome
Pediatric and Adolescent Health
• August 2026
• 2.00 Credits
The Pharmacist's Guide to Head Lice Treatment
×
Full Image